Document:

Amendment to Amended and Restated Employment Agreement - Daniel E. Rosati

 EXHIBIT 10.30 
 AMENDMENT TO AMENDED AND RESTATED 
 EMPLOYMENT AGREEMENT 

Dated as of August 8, 2011 
 Reference is made to that certain Amended and Restated Employment Agreement (the “Original Agreement”), dated as of the Effective Date as defined therein, by and among TMS International
Corp. (formerly Metal Services Acquisition Corp.), a Delaware corporation, Tube City IMS Corporation, a Delaware corporation (the “Company”), and Daniel E. Rosati (the “Executive”). Capitalized terms used but not otherwise
defined herein shall have the meanings given to them in the Original Agreement. 
 For good and valuable consideration
(including the promises set forth herein), the receipt and sufficiency of which are hereby acknowledged, each of the Company and Executive intending to be legally bound, hereby agree as follows: 

1. Amendment. 
  

	 	A.	Section 2B(b) of the Original Agreement is amended and restated in its entirety as follows: 

“(b) In addition to the Base Salary, during the Employment Period, Executive will be eligible to earn an annual bonus under a bonus
plan to be established by the Company, as determined by the Board, in its sole discretion based upon the Company’s achievement of budgetary and other objectives set by the Board;. Bonus compensation earned and payable pursuant to this
Section 2B(b), if any, shall be paid in accordance with the Company’s customary practices in the calendar year following the fiscal year for which the bonus is earned, and in no event shall such payment be made later than
December 31 of such following calendar year.” 
  

	 	B.	Section 2C(a) of the Original Agreement is amended and restated in its entirety as follows: 

“(a) The Employment Period shall begin on the Effective Date and end on December 31, 2014, and shall automatically be extended
by one year as of January 1, 2015 at each January 1 anniversary date thereafter on the same terms and conditions set forth herein, as modified from time to time by the parties hereto, unless the Company or Executive gives the other party
written notice of election not to so extend the Employment Period at least sixty (60) days prior to any such extension date; provided that (i) the Employment Period shall terminate prior to such date immediately upon the death or
Disability 

 
of Executive, (ii) the Employment Period may be terminated by the Company at any time prior to such date with or without Cause and (iii) the Employment Period may be terminated by
Executive at any time prior to such date.” 
  

	 	C.	Section 2C(b) of the Original Agreement is amended and restated in its entirety as follows: 

“(b) If the Employment Period is terminated (i) by the Company without Cause, (ii) by Executive for Good Reason, or
(iii) because the Company elects not to renew the Employment Period and as a result Executive is no longer employed by the Company or its subsidiaries on substantially the same terms as set forth herein, Executive shall be entitled to receive
the Base Salary through the date of termination plus a “Severance Payment” equal to two (2) times the Base Salary. The Severance Payment shall be payable in equal monthly installments over a period of two (2) years.
In addition, (i) the Company shall provide Executive with executive-level outplacement services from an outplacement company selected by the Company, provided that the Company shall not be required to spend more than Ten Thousand Dollars
($10,000) for such services, and (ii) during the period over which the Severance Payment is made, Executive shall, to the extent permitted by the non-discrimination requirements of the Patient Protection and Affordable Care Act, without
subjecting the Company to an excise tax under the Internal Revenue Code (“Code”) and to the extent permitted by the Company’s health insurance carrier (if applicable), be entitled to continued health coverage on the same basis
that such coverage was provided to Executive prior to the termination of the Employment Period, provided that coverage shall end earlier if and when Executive becomes entitled to comparable coverage under another employer’s health plan (and, if
applicable, shall be secondary to Medicare to the extent permitted by law) and that Executive acknowledges and agrees that he will be solely responsible for all taxes imposed upon him under the Code by reason of receiving such coverage. In lieu of
such continuing health coverage, Executive may elect to have the Company pay Executive each month during the period over which the Severance Payment is made an amount equal to the amount that the Company would pay to provide health coverage to
Executive, on the same basis that such coverage was provided to Executive prior to the termination of the Employment Period, if Executive was still employed by the Company, unless such election is prohibited by applicable law. As a condition to the
Company’s obligations to make the Severance Payment to Executive pursuant to this Section 2C(b), Executive must (a) continue to comply with the restrictive covenants contained in Section 3, and (b) execute and
deliver a general release agreement in form and substance satisfactory 

  
 2 

 
to the Company. Executive must sign and tender the release as described in the immediately preceding sentence not later than sixty (60) days following Executive’s last day of
employment, or such earlier date as required by the Company, and if Executive fails or refuses to do so, Executive shall forfeit the right to the Severance Payment as would otherwise be due and payable. If the Severance Payment is otherwise subject
to Section 409A of the Code (“Section 409A”) and except as otherwise required by Section 2D, the first installment shall be made on the first pay period following the date that is sixty (60) days after
Executive’s employment terminates and shall otherwise be made on the first pay period after the release becomes effective (with the initial salary continuation payment to include any unpaid salary continuation payments from the date
Executive’s employment terminated), subject to Executive’s executing and tendering the release on the terms as set forth in the immediately preceding sentence.” 

 

	 	D.	Section 2 of the Original Agreement is amended by inserting the following Section 2D after Section 2C: 

“Section 2D. Section 409A. 
 (a) The Company and Executive intend that the payments and benefits provided for in this Agreement either be exempt from Section 409A, or be provided in a manner that complies with Section 409A,
and any ambiguity herein shall be interpreted so as to be consistent with the intent of this Section 2D. In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed on Executive by
Section 409A or damages for failing to comply with Section 409A. Notwithstanding anything contained herein to the contrary, all payments and benefits under Section 2 shall be paid or provided only at the time of a termination
of Executive’s employment that constitutes a “separation from service” from the Company within the meaning of Section 409A and the regulations and guidance promulgated thereunder (determined after applying the presumptions set
forth in Treas. Reg. Section 1.409A-1(h)(1)). Further, if at the time of Executive’s termination of employment with the Company, Executive is a “specified employee” as defined in Section 409A as determined by the Company in
accordance with Section 409A, and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of employment is necessary in order to prevent any accelerated or additional tax under
Section 409A, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in payments or benefits ultimately paid or provided to Executive) until the later of (i) the date
that is at 

  
 3 

 
least six (6) months following Executive’s termination of employment with the Company and (ii) the date that is eighteen (18) months following the effective date of the
Amendment to this Agreement (or the earliest date permitted under Section 409A of the Code). Thereafter, payments will commence and continue in accordance with this Agreement until paid in full. 

(b) Notwithstanding anything to the contrary in this Agreement, in-kind benefits and reimbursements provided under this
Agreement during any calendar year shall not affect in-kind benefits or reimbursements to be provided in any other calendar year, other than an arrangement providing for the reimbursement of medical expenses referred to in Section 105(b) of the
Code, and are not subject to liquidation or exchange for another benefit. Notwithstanding anything to the contrary in this Agreement, reimbursement requests must be timely submitted by Executive and, if timely submitted, reimbursement payments shall
be promptly made to Executive following such submission, but in no event later than December 31 of the calendar year following the calendar year in which the expense was incurred. In no event shall Executive be entitled to any reimbursement
payments after December 31 of the calendar year following the calendar year in which the expense was incurred. This Section 2D(b) shall only apply to in-kind benefits and reimbursements that would result in taxable compensation
income to Executive.” 
  

	 	E.	The Original Agreement is amended by deleting Section 3F in its entirety and renumbering Sections 3G and 3H accordingly, and by deleting Section 4D(h) in its
entirety. 

 2. Miscellaneous. Except as modified hereby, the provisions of the Original Agreement, shall
remain unmodified, and, subject to the amendments contained herein, the Original Agreement is hereby confirmed as having been validly executed and delivered by each of the undersigned and as being in full force and effect. This Amendment may be
executed in any number of counterparts which together shall constitute one instrument, shall be governed by and construed in accordance with the substantive laws of the State of New York, without reference to or giving effect to any choice or
conflict of laws provision or rule that would cause the application of the domestic substantive laws of any other jurisdiction. 

[Remainder of page intentionally left blank] 

  
 4 

 IN WITNESS WHEREOF, the undersigned have caused this Amendment to the Amended and Restated
Employment Agreement to be executed and delivered as of the date first above written. 
  

			
	TMS INTERNATIONAL CORP.
		
	By:	 	 /s/ Thomas E. Lippard

		 	Name: Thomas E. Lippard
		 	Title: Executive Vice President
	
	TUBE CITY IMS CORPORATION
		
	By:	 	 /s/ Thomas E. Lippard

		 	Name: Thomas E. Lippard
		 	Title: Executive Vice President
	
	 /s/ Daniel E. Rosati

	Daniel E. Rosati

  
 5Form of Hawker Beechcraft, Inc. Restricted Stock Unit Agreement for Exchange

 Exhibit 10.1 
 HAWKER BEECHCRAFT, INC. 
 RESTRICTED STOCK UNIT AGREEMENT 

THIS AGREEMENT, made as of August 9, 2011 (the “Date of Grant”), between Hawker Beechcraft, Inc., a Delaware
corporation (the “Company”), and [            ] (the “Grantee”). 
 R E C I T A L S: 

WHEREAS, the Grantee holds options to purchase shares of the Company as set forth on Exhibit A to this Agreement
(“Options”); 
 WHEREAS, the Board has established a program (the “Exchange Program”) whereby
the Grantee was offered the opportunity to exchange the Options for Restricted Stock Units; 
 WHEREAS, pursuant to the terms of
the Exchange Program, the Grantee desires to exchange the Options for Restricted Stock Units (as defined below) as set forth in this Agreement; and 
 WHEREAS, the Grantee acknowledges that (i) he/she has read and understands the Disclosure Document (as defined below) and has had the opportunity to ask questions of the Company with respect to the
Exchange Program and (ii) as of the date hereof, the Options shall be of no further force and effect and the Grantee shall have no further rights with respect to the Options or Shares underlying the Options. 

NOW THEREFORE, in consideration of the mutual covenants hereinafter set forth, the parties agree as follows: 

1. Grant. 
 The Company hereby grants to the Grantee an award (the “Award”) of restricted stock units (the “Restricted Stock Units” or “RSUs”) in exchange for the
Options as set forth on Exhibit A. For the avoidance of doubt, each separately identified Option set forth on Exhibit A shall be treated as if it were exchanged for a separate number of RSUs as set forth therein, and this Agreement
shall be construed accordingly. Unless the context requires otherwise, references to the “Restricted Stock Units” or “RSUs” hereinafter shall refer to each such separate number of RSUs. The Restricted Stock Units granted pursuant
to the Award and the exchange of Options therefor shall be subject to the execution and return of this Agreement by the Grantee to the Company. Subject to the terms of this Agreement, each Restricted Stock Unit represents the right to receive one
(1) Share at the time and in the form and manner set forth in Section 7 hereof. 
 2. Representation and Warranty
of Grantee. 
 The Grantee has reviewed this Agreement and the Offer to Exchange (the “Disclosure
Document”) and has had the opportunity to ask questions and receive answers 

 
concerning the terms and conditions of this Agreement, the Disclosure Document and the Exchange Program. The Grantee has had full access to such other information concerning this Agreement, the
Disclosure Document and the Exchange Program as the Grantee has requested, and has had the opportunity to consult with Grantee’s legal and financial advisors regarding this Agreement, the Disclosure Document and the Exchange Program. The
Grantee acknowledges that the Exchange Program provides for the exchange of the Options for Restricted Stock Units and that after the exchange the Options shall be of no further force and effect and the Grantee shall have no further rights
thereunder. By reason of the Grantee’s business and financial experience and the business and financial experience of those Persons retained to advise the Grantee with respect to the Exchange Program, the Grantee has such knowledge,
sophistication and experience in business and financial matters that the Grantee is capable of evaluating the merits and consequences of the transactions contemplated by the Exchange Program. 

3. Accrual of Restricted Stock Units. 
 Subject to the Grantee’s continued employment with a member of the Company Group through the applicable date of accrual, the Restricted Stock Units shall accrue 20% per year commencing on the
first anniversary of the Vesting Commencement Date of the Options exchanged for such Restricted Stock Units as set forth on Exhibit A hereto. Notwithstanding the foregoing, (a) if prior to any voluntary or involuntary termination of the
Grantee’s employment with any member of the Company Group (a “Termination”), there occurs (i) a Change in Control or (ii) the sale of all or substantially all of the assets or equity interests of the subsidiary,
business unit or division in which the Grantee is employed, and as a result thereof, the Grantee is no longer employed by any member of the Company Group (a “Qualifying Sale”), the Grantee shall become fully accrued with respect to
the Restricted Stock Units and (b) in the event of an involuntary Termination due to the Grantee’s death or Disability, the Grantee shall become accrued in an additional 20% of the Restricted Stock Units. Restricted Stock Units that have
accrued pursuant to this Section 3 are referred to herein as “Accrued RSUs.” 
 4. Termination of
Employment. 
 4.1. In the event of an involuntary Termination by the Grantee’s employer without Cause or due to the
Grantee’s death or Disability, the Grantee shall be entitled to an issuance of Shares with respect to Restricted Stock Units that are Accrued RSUs as of the date of such Termination in accordance with Section 7. Restricted Stock Units that
are not Accrued RSUs as of such date shall be forfeited for no consideration. 
 4.2. Upon a Termination other than as set
forth in Section 4.1 of this Agreement, the Grantee shall forfeit all outstanding Restricted Stock Units, whether or not such Restricted Stock Units are Accrued RSUs. 
 5. Non-Transferability. 
 The Award may not be assigned, alienated,
pledged, attached, sold or otherwise transferred or encumbered by the Grantee; provided that the designation of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance. 

  
 2 

 6. No Right to Continued Employment. 

The granting of the Award evidenced hereby and this Agreement shall impose no obligation on the Company or any other member of the
Company Group to continue the employment of the Grantee and shall not lessen or affect the Company’s or such other member’s right to terminate the employment of such Grantee. 

7. Settlement of Restricted Stock Units. 
 7.1. Within ten (10) days following the earliest of (i) the date of the consummation of a Change in Control, (ii) the Grantee’s Termination pursuant to Section 4.1 of this
Agreement, (iii) the date of the consummation of a Qualifying Sale or (iv) the date of the expiration of the underwriter’s lockup agreed to by the Company in an IPO, the Company shall issue to Grantee (or, if applicable, the
Grantee’s estate) one (1) Share with respect to each Restricted Stock Unit that is an Accrued RSU as of the date of such event (including, for the avoidance of doubt, Restricted Stock Units that become Accrued RSUs due to the occurrence of
such event). In the case of an issuance pursuant to clause (i) of this Section 7.1, the Company may provide for such issuance prior to, but subject to the consummation of, the Change in Control. 

7.2. Following the occurrence of an IPO, but subject to Section 3 and Section 4 of this Agreement, the Grantee’s
outstanding Restricted Stock Units shall continue to accrue in accordance with the schedule set forth in Section 3. Within ten (10) days following such Restricted Stock Units becoming Accrued RSUs pursuant to Section 3, the Company
shall issue to Grantee one (1) Share with respect to each such Accrued RSU. For the avoidance of doubt, the Grantee shall not be entitled to an issuance of a Share with respect to an Accrued RSU with respect to which an issuance has already
been made pursuant to Section 7.1 or this Section 7.2 of this Agreement. 
 7.3. The issuance of Shares pursuant to
this Agreement shall be subject to and conditioned upon the Grantee’s execution of the Shareholders Agreement. Notwithstanding anything to the contrary contained herein, no Shares shall be issued to any person other than the Grantee unless such
other person presents documentation to the Company, which demonstrates to the reasonable satisfaction of the Company such person’s right to the transfer. 
 8. Unauthorized Disclosure; Non-Solicitation; Interference with Business Relationships; Proprietary Rights. 
 8.1. Unauthorized Disclosure. The Grantee agrees and understands that in the Grantee’s position with the Company Group, the Grantee has been and will be exposed to and has and will receive
information relating to the confidential affairs of the Company Group, including, without limitation, technical information, intellectual property, business and marketing plans, strategies, customer information, software, other information
concerning the products, promotions, development, financing, expansion plans, business policies and practices of the Company and its Affiliates and other forms of information considered by the Company and its Affiliates to be confidential or in the
nature of trade secrets (including, without 

  
 3 

 
limitation, ideas, research and development, know-how, formulas, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information and business and
marketing plans and proposals) (collectively, the “Confidential Information”). Confidential Information shall not include information that is generally known to the public or within the relevant trade or industry other than due to
the Grantee’s violation of this Section 8.1 or disclosure by a third party who is known by the Grantee to owe the Company an obligation of confidentiality with respect to such information. The Grantee agrees that at all times during the
Grantee’s employment with the Company Group and thereafter, the Grantee shall not disclose such Confidential Information, either directly or indirectly, to any Person without the prior written consent of the Company and shall not use or attempt
to use any such information in any manner other than in connection with his employment with the Company Group, unless required by law to disclose such information, in which case the Grantee shall provide the Company with written notice of such
requirement as far in advance of such anticipated disclosure as possible. This confidentiality covenant has no temporal, geographical or territorial restriction. Upon termination of the Grantee’s employment with any member of the Company Group,
the Grantee shall promptly supply to such member all property, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs, machines, technical data and any other tangible product
or document which has been produced by, received by or otherwise submitted to the Grantee during or prior to the Grantee’s employment with the Company Group, and any copies thereof in his (or capable of being reduced to his) possession.

 8.2. Non-Solicitation of Employees. During the 12-month period following the Grantee’s Termination for any
reason, the Grantee shall not directly or indirectly contact, induce or solicit (or assist any Person to contact, induce or solicit) for employment any person who is, or within twelve (12) months prior to the date of such solicitation was, an
employee of any member of the Company Group or any of their Affiliates. 
 8.3. Interference with Business
Relationships. During the 24-month period following the Grantee’s Termination for any reason, the Grantee shall not directly or indirectly contact, induce or solicit (or assist any Person to contact, induce or solicit) any customer or
client of the Company Group to terminate its relationship or otherwise cease doing business in whole or in part with the Company Group, or directly or indirectly interfere with (or assist any Person to interfere with) any material relationship
between any member of the Company Group and any of its customers or clients so as to cause harm to the Company Group. 
 8.4.
Proprietary Rights. The Grantee shall disclose promptly to the Company any and all inventions, discoveries, and improvements (whether or not patentable or registrable under copyright or similar statutes), and all patentable or copyrightable
works, initiated, conceived, discovered, reduced to practice, or made by him, either alone or in conjunction with others, during the Grantee’s employment with the Company Group and related to the business or activities of the Company and its
Affiliates (the “Developments”). Except to the extent any rights in any Developments constitute a work made for hire under the U.S. Copyright Act, 17 U.S.C. § 101 et seq. that are owned ab initio by the Company and/or its
applicable Affiliate, the Grantee assigns all of his right, title and interest in all Developments (including all intellectual property rights therein) to the Company or its nominee without further compensation, including all rights or benefits
therefor, including without limitation the right to 

  
 4 

 
sue and recover for past and future infringement. The Grantee acknowledges that any rights in any Developments constituting a work made for hire under the U.S. Copyright Act, 17 U.S.C § 101
et seq. are owned upon creation by the Company and/or its applicable Affiliate as the Grantee’s employer. Whenever requested to do so by the Company, the Grantee shall execute any and all applications, assignments or other instruments which the
Company shall deem necessary to apply for and obtain trademarks, patents or copyrights of the United States or any foreign country or otherwise protect the interests of the Company and its Affiliates therein. These obligations shall continue beyond
the end of the Grantee’s employment with the Company Group with respect to inventions, discoveries, improvements or copyrightable works initiated, conceived or made by the Grantee while employed by the Company Group, and shall be binding upon
the Grantee’s employers, assigns, executors, administrators and other legal representatives. In connection with his or her execution of this Agreement, the Grantee has informed the Company in writing of any interest in any inventions or
intellectual property rights that he or she holds as of the date hereof. If the Company is unable for any reason, after reasonable effort, to obtain the Grantee’s signature on any document needed in connection with the actions described in this
Section 8.4, the Grantee hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as the Grantee’s agent and attorney in fact to act for and on the Grantee’s behalf to execute, verify and file
any such documents and to do all other lawfully permitted acts to further the purposes of this Section 8.4 with the same legal force and effect as if executed by the Grantee. 

9. Adjustment Upon Certain Events. 
 In the event of any Share dividend, Share split or, reverse split, reorganization, reclassification, recapitalization, merger, consolidation, spin-off, split-up, combination or exchange of Shares or other
similar corporate transaction, or any extraordinary dividend or distribution to shareholders of Shares, the Board, without liability to any Person, shall take such actions as it in its sole discretion deems appropriate to preserve the intended
benefits of the Restricted Stock Units to the Grantee, by adjusting the terms of the Restricted Stock Units or such other means as the Board shall determine and, in any event, in compliance, to the extent applicable, with Section 409A of the
Code. 
 10. Legend on Certificates. 
 The certificates representing the Shares issued pursuant to this Award shall be subject to such stop transfer orders and other restrictions as the Company may deem advisable under the rules, regulations,
and other requirements of the Securities and Exchange Commission and any stock exchange upon which such Shares are listed, and any applicable federal or state laws, and the Company may cause a legend or legends to be put on any such certificates to
make appropriate reference to such restrictions. 
 11. Securities Laws. 

Prior to the issuance of any Shares pursuant to this Award, the Grantee will make or enter into such written representations, warranties
and agreements as the Company may reasonably request in order to comply with applicable securities laws or with this Agreement. 

  
 5 

 12. Withholding of Taxes. 

Whenever Shares, cash or other consideration is to be issued pursuant to this Award, the Company shall have the right to require the
Grantee to remit to the Company cash sufficient to satisfy all federal, state and local withholding tax requirements prior to issuance of the Shares and the delivery of any certificate or certificates for such Shares or the payment of cash or other
consideration. If approved in the discretion of the Chairman of the Compensation Committee of the Board or his designee, the Grantee may satisfy such tax withholding obligation by surrendering to the Company on the date of issuance Shares having a
Fair Market Value on that date equal to the withholding taxes. 
 13. Modification of Agreement. 

This Agreement may be modified, amended, suspended or terminated, and any terms or conditions may be waived, but only by a written
instrument executed by the parties hereto. 
 14. Severability. 

Should any provision of this Agreement be held by a court of competent jurisdiction to be unenforceable or invalid for any reason, the
remaining provisions of this Agreement shall not be affected by such holding and shall continue in full force in accordance with their terms. 
 15. Governing Law. 
 The validity, interpretation, construction and
performance of this Agreement shall be governed by the laws of the State of New York without giving effect to the conflicts of laws principles thereof. 
 16. Notices. 
 Any notice necessary under this Agreement shall be addressed
to the Company in care of its Secretary at the principal executive office of the Company and to the Grantee at the address appearing in the personnel records of the Company for the Grantee or to either party hereto at such other address as either
party may hereafter designate in writing to the other. Any such notice shall be deemed effective upon receipt thereof by the addressee. 
 17. Successors in Interest. 
 This Agreement shall inure to the benefit of
and be binding upon any successor to the Company. This Agreement shall inure to the benefit of the Grantee’s legal representatives, heirs, executors, administrators and successors. All obligations imposed upon the Grantee and all rights granted
to the Company under this Agreement shall be binding upon the Grantee’s heirs, executors, administrators and successors. 

  
 6 

 18. Definitions. 

The following capitalized terms used in this Agreement have the respective meanings set forth in this Section: 

18.1. Affiliate: With respect to any Person, any other Person directly or indirectly controlling or controlled by or under direct
or indirect common control with such specified Person. 
 18.2. Board: The Board of Directors of the Company.

 18.3. Cause: With respect to a Grantee’s Termination, (a) if the Grantee is at the time of Termination a
party to an employment or retention agreement that defines such term, the meaning given therein, and (b) in all other cases, (i) conviction of the Grantee of a felony or a crime involving moral turpitude (excluding in each case vehicular
offenses), or other act or willful omission involving dishonesty or fraud with respect to any member of the Company Group, in each case, which causes material harm to the standing and reputation of any member of the Company Group and after written
notice to the Grantee, (ii) other than by reason of death or Disability, the Grantee’s continued failure to perform his duties to the Company Group and/or deliberate failure or deliberate refusal by the Grantee to comply with a reasonable
written directive of the Board, or the Chief Executive Officer or other executive officer of Hawker Beechcraft Corporation which is consistent with the method and manner of conducting the business of the Company Group as it is now being conducted,
or failure or refusal to comply with the Company Group policies, which, after written notice thereof, if susceptible to remedy or cure is not cured or remedied and continues for fifteen (15) business days after receipt of such notice or
(iii) the Grantee’s violation of any of the covenants set forth in Section 8 of this Agreement. 
 18.4.
Change in Control: A Change in Control shall occur on the earliest of (i) the date that any one Person or more than one Person acting as a group acquires ownership of stock of the Company that, together with stock held by such person or
group, constitutes more than 50% of the total Fair Market Value or total voting power of the stock of the Company; (ii) following an IPO, the date that any one Person, or more than one Person acting as a group, acquires (or has acquired during
the 12-month period ending on the date of the most recent acquisition by such Person or group) ownership of stock of the Company possessing 30% or more of the total voting power of the stock of the Company or (iii) the date that any Person, or
more than one Person acting as a group, acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such Person or group) all or substantially all of the assets of the Company, in each case, other than
an acquisition by any Person who is a member of the Existing Owner Group. Notwithstanding the foregoing, a transaction shall not constitute a Change in Control unless such transaction constitutes a “change in ownership or effective
control” of the Company or a “change in ownership of a substantial portion of the assets” of the Company within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance
thereunder. 
 18.5. Company Group: Collectively, the Company, its subsidiaries and its or their respective successors
and assigns. 

  
 7 

 18.6. Disability: (a) If the Grantee is at the time of Termination a party to
an employment or retention agreement that defines such term, the meaning given therein, and (b) in all other cases, the Grantee is unable to perform by reason of physical or mental incapacity his or her duties or obligations to the Company
Group for a period of one hundred twenty (120) consecutive calendar days or a total period of two hundred ten (210) calendar days in any three hundred sixty (360) calendar day period. 

18.7. Existing Owner Group: Onex Corporation, GS Capital Partners VI, L.P., GS Capital Partners VI Parallel, L.P., GS Capital
Partners VI Offshore, L.P. and GS Capital Partners VI GmgH & Co. KG, and any Affiliate of any of the foregoing, which invests in equity of the Company Group. 
 18.8. Fair Market Value: On a given date, (i) if there should be a public market for the Shares on such date, the arithmetic mean of the high and low prices of the Shares as reported on such
date on the composite tape of the principal national securities exchange on which such Shares are listed or admitted to trading, or, if the Shares are not listed or admitted on any national securities exchange, the arithmetic mean of the per-Share
closing bid price and per-Share closing asked price on such date as quoted on the National Association of Securities Dealers Automated Quotation System (or such market in which such prices are regularly quoted) (“Nasdaq”), or, if no sale
of Shares shall have been reported on the composite tape of any national securities exchange or quoted on the Nasdaq on such date, the arithmetic mean of the per-Share closing bid price and per-Share closing asked price on the immediately preceding
date on which sales of the Shares have been so reported or quoted, and (ii) if there is not a public market for the Shares on such date, the value established by the Board in good faith. 

18.9. IPO: The later of (i) the completion of a Public Offering of the Shares at the conclusion of which the aggregate value
of Shares that have been sold to the public pursuant to such Public Offering, when aggregated with any previous Public Offerings is equal to or exceeds $50 million and pursuant to which the Company becomes listed on a national securities exchange or
on the Nasdaq Stock Market or Nasdaq National Market or (ii) in connection with an offering described in clause (i), the day following the last day of the period following such offering during which transfers of the Shares are prohibited
pursuant to a request by the lead underwriter in such offering. 
 18.10. Person: An individual, corporation, limited
liability company, limited or general partnership, joint venture, association, joint-stock company, trust, unincorporated organization or other entity or organization, including a government or political subdivision or an agency or instrumentality
thereof. 
 18.11. Public Offering: The sale of Shares to the public pursuant to an effective registration statement
(other than a registration statement on Form S-4 or S-8 or any similar or successor form) filed under the Securities Act in connection with an underwritten offering. 
 18.12. Shareholders Agreement: The Shareholders Agreement dated as of May 3, 2007 (as amended and restated from time to time) by and among the Company and such other Persons who are or become
parties thereto. 

  
 8 

 18.13. Shares: Shares of common stock, par value $.01 per share, of the Company and
any other securities into which such shares of common stock are changed or for which such shares of common stock are exchanged. 

19. Signature in Counterparts. 
 This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. 

[Signature page follows] 

  
 9 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date and year first
above written. 
  

			
	HAWKER BEECHCRAFT, INC.
		
	By:	 	  

			
	Name:	 	
             

			
	Title:	 	              

	
	GRANTEE
	
	  

 EXHIBIT A 

 

									
	 Date of Grant of Option
	  	Number and
Type of Option
Shares being
Exchanged	  	Exercise Price
for Options
being
Exchanged	  	Vesting
Commencement
Date of
Exchanged
Options	  	Number of
RSUs Received
for Exchanged
Options

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}]]